This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

High-risk compound

Surface here is educational only; do not use without medical supervision. Our editorial verdict is SKIP-FOR-NOW — current cost / risk / redundancy puts it below the line.

Browse

AICAR

The original "exercise in a pill" — direct AMPK activator that gave sedentary mice +44% endurance in Narkar 2008.

Aliases (4)
Acadesine · AICA-riboside · 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside · GP531
TYPICAL DOSE
ROUTE
CYCLE
STORAGE

Overview

What is AICAR?

The original "exercise in a pill" — direct AMPK activator that gave sedentary mice +44% endurance in Narkar 2008. In humans: near-zero oral bioavailability, injection-only, no FDA-approved form, WADA-banned, and same gray-market supply chain as worst of the AAS world. Metformin / berberine / actual exercise hit the same target with vastly better risk profile.

What to Expect

  • Week 1
    Tolerability and dose-response.
  • Week 2-4
    Early effect window.
  • Week 4-8
    Peak benefit assessment.
  • Week 8+
    Cycle decision point.
Was this helpful?
Your feedback shapes what we research deeper.

How was your experience with this compound?

Anonymous · one vote per session · results below at 5+ votes.

Loading…

See something off?

Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.

Discussion — click to load
Loading…
Continue: Extended research →
Our verdict, decision matrix, deep dives, controversies, sources